Anauxetic dysplasia 2 is a rare genetic condition that affects bone growth and body size. People with Anauxetic dysplasia 2 often have very short stature, spine and rib differences, and joint stiffness that can cause fatigue or pain with activity. Signs are usually recognized in infancy or early childhood and continue lifelong, though day‑to‑day needs vary. Breathing issues, spinal curvature, or airway narrowing can occur, and severity can range from mild to serious. Care focuses on monitoring growth and the spine, breathing and sleep support, physical therapy, and surgery when needed, and the outlook depends on how severe the skeletal and airway features are.
Overview
Anauxetic dysplasia 2Symptoms
In Anauxetic dysplasia 2, features at birth include extreme short length, short limbs, and a small chest. Many develop curvature, joint laxity or contractures, bowed legs, and delayed motor milestones; facial differences may occur, while learning and intelligence are typical.
Outlook and prognosis
Many people with Anauxetic dysplasia 2 grow very slowly, with short stature and spine or joint changes that may affect daily activities. With coordinated care—orthopedics, physical therapy, dental and hearing support—most can attend school, work, and build independent routines. Progress is gradual; regular monitoring helps prevent complications and plan helpful interventions.
Causes and risk factors
Anauxetic dysplasia 2 results from harmful changes in the POP1 gene, usually inherited in an autosomal-recessive pattern. Risk rises when both parents are carriers, including in consanguineous families. It starts before birth; environment and lifestyle don’t cause it.
Genetic influences
Genetics are central in Anauxetic dysplasia 2. It’s caused by inherited changes in a single gene, and most cases follow autosomal recessive patterns. Genetic testing confirms the diagnosis, guides family planning, and helps estimate recurrence risk for future pregnancies.
Diagnosis
Doctors suspect Anauxetic dysplasia 2 from clinical features of severe, proportionate short stature and characteristic skeletal changes on X-rays. Genetic tests confirming POP1 variants establish the genetic diagnosis of Anauxetic dysplasia 2. Additional imaging and growth records help assess severity.
Treatment and drugs
Treatment for Anauxetic dysplasia 2 focuses on supportive, coordinated care. This often includes growth hormone only when clearly indicated, careful spine and limb management, physical therapy, pain control, and monitoring of breathing, hearing, and dental health. Genetic counseling helps families plan care.
Symptoms
Living with Anauxetic dysplasia 2 mainly affects growth and the skeleton, starting early in life. Parents often spot early features of Anauxetic dysplasia 2 in infancy, like very slow length and height growth and joints that feel unusually flexible. Features vary from person to person and can change over time. In day-to-day life, it can affect posture, movement, stamina, and sometimes breathing during colds.
Very small length and height from infancy, with much slower growth than peers. In Anauxetic dysplasia 2, this difference is usually present from birth. Clothing, car seats, and mobility devices often need to be tailored.
The back may round or twist over time, leading to a hunched or S-shaped posture. This can reduce height further and cause back discomfort.
Joints can be overly flexible and less stable. This may lead to sprains, clumsiness, or fatigue after play or walking.
The hip may be angled differently, causing a wide-based or waddling walk. In Anauxetic dysplasia 2, hip pain after longer walks and early joint wear can occur.
How people usually first notice Anauxetic dysplasia 2?
Families often notice the first signs of anauxetic dysplasia 2 in infancy when a baby’s length and growth fall far below the expected curve despite good feeding and overall alertness. Doctors may first suspect it at birth or during early check-ups because of strikingly short stature, a very small body with relatively average head size, and early skeletal features on exam or X-ray, such as unusually shaped vertebrae and pelvis. In many cases, how anauxetic dysplasia 2 is first noticed is through routine growth measurements and imaging after parents or clinicians raise concerns about persistent, severe short stature.
Types of Anauxetic dysplasia 2
Anauxetic dysplasia 2 is a rare genetic skeletal condition with recognized clinical variants that can affect height, bones, and sometimes teeth and joints to different degrees. Variants are usually defined by the specific gene change and how strongly it disrupts normal bone growth. Not everyone will experience every feature, and severity can range from mild to more pronounced. People may notice different sets of symptoms depending on their situation.
PCYT1A-related classic
This variant is linked to changes in the PCYT1A gene and is the most widely described form. It often involves proportionate but marked short stature, small hands and feet, and characteristic spine and pelvic changes on X‑ray.
PCYT1A milder variant
Some PCYT1A changes lead to a less severe presentation. People with this type may have short stature with fewer bone changes, and may notice milder dental or joint findings.
Biallelic loss severe
When both PCYT1A copies are strongly affected, features can be more pronounced. This variant may include very short adult height, earlier-onset spine curvature, and more noticeable limb and pelvic differences.
Heterozygous partial effect
Certain single-copy (dominant) PCYT1A variants can produce a subtler skeletal picture. This variant may present with mild short stature and limited radiographic changes, sometimes found only during family screening.
Dental/joint-predominant
In some families, PCYT1A variants show more dental enamel or joint laxity issues than spine or limb changes. Daily life often makes the differences between symptom types clearer, with chewing, walking, or grip tasks bringing these features to attention.
What genetics can tell you about symptoms
Some people with Anauxetic dysplasia 2 develop extreme short stature, spine and joint stiffness, and early-onset bone changes because mutations in the RNU4ATAC gene disrupt a cell process called minor splicing. This disturbance alters growth‑plate cartilage and bone development, linking the variant to skeletal features.
Causes and risk factors
Anauxetic dysplasia 2 happens because of harmful changes in the POP1 gene, usually in both copies. It is inherited in an autosomal recessive way, so two healthy carriers have a 25% (1 in 4) chance in each pregnancy. Some risks are written in our DNA, passed down through families, so family genetic testing can help even before early symptoms of Anauxetic dysplasia 2 are noticed. Risk is higher when parents are related by blood or there is a known family history. Lifestyle and environmental factors do not cause the condition, but good nutrition and routine medical care can influence how severe the bone and growth features become.
Environmental and biological risk factors
Here’s what we know about environmental and biological risk factors for Anauxetic dysplasia 2. Doctors often group risks into internal (biological) and external (environmental). For this rare condition, research so far has not found specific outside exposures that raise risk. Most factors that influence other birth conditions do not appear to change the likelihood of Anauxetic dysplasia 2.
The condition starts during the earliest stages of embryo development. Later pregnancy events do not change whether it occurs.
No specific environmental exposures (such as radiation, heavy metals, or air pollution) are proven to raise the chance of Anauxetic dysplasia 2. Current studies have not identified workplace or household exposures that alter risk.
Unlike some conditions tied to older maternal or paternal age, Anauxetic dysplasia 2 has not been clearly linked to age at conception. It can occur in pregnancies across a wide age range.
Common pregnancy conditions, including diabetes, thyroid disease, or infections, have not been shown to cause this diagnosis. These conditions may affect pregnancy in other ways, but they have not been linked to higher risk here.
Genetic risk factors
Anauxetic dysplasia 2 is linked to changes in a single gene that guide how growing cartilage becomes bone. Some risk factors are inherited through our genes. Understanding the genetic causes of Anauxetic dysplasia 2 can help with family planning and testing options. Your care team can explain how these apply to your family.
POP1 gene changes: Anauxetic dysplasia 2 is caused by changes in the POP1 gene. POP1 helps a cell complex handle RNA needed for normal cartilage and bone growth. Genetic testing can identify these changes.
Autosomal recessive pattern: The condition appears when both copies of POP1 carry a non-working change. Parents are usually healthy carriers and have a 25% chance in each pregnancy of having a child with Anauxetic dysplasia 2. Siblings each have a 50% chance to be carriers.
Compound variants: Many children inherit two different POP1 changes, one from each parent. This still results in too little working POP1. The clinical features are comparable to having the same change on both copies.
Related parents: When parents are related by blood, they are more likely to carry the same rare POP1 variant. This increases the chance that a child inherits two non-working copies. Genetic counseling can help estimate this risk.
Family history: A sibling or relative with Anauxetic dysplasia 2, or a known POP1 variant in the family, raises the chance that others are carriers. Testing relatives can clarify who carries the change. This can guide reproductive planning.
Variant effect differences: Different POP1 changes can leave varying amounts of function. This can partly explain why features vary between people with Anauxetic dysplasia 2. Still, predictions from the DNA result alone are limited.
Molecular testing: Sequencing of POP1 confirms the diagnosis and carrier status. Once the family-specific change is known, options like prenatal or preimplantation testing may be available. A genetics team can discuss benefits and limits.
Lifestyle risk factors
Anauxetic dysplasia 2 is a genetic condition; lifestyle habits do not cause it, but they can influence day-to-day function, symptom control, and complications. Focusing on how lifestyle affects Anauxetic dysplasia 2 can help protect joints, spine, and mobility over time. The following elements highlight practical choices that matter for comfort, safety, and participation in daily life. These are the lifestyle risk factors for Anauxetic dysplasia 2 that families and adults can modify with their care team.
Repetitive jumping, running, or collision sports can increase stress on small, dysplastic joints and the spine. Choosing low-impact activities (like swimming or cycling) reduces pain flares and may slow activity-related wear.
Long bouts of standing or walking without breaks can trigger joint pain and fatigue in short-limbed skeletal dysplasia. Planned rests and alternating tasks help preserve function across the day.
Skipping therapy or unsupervised aggressive stretching can worsen instability around hypermobile joints. A tailored program emphasizing core and hip strength supports posture and protects the spine.
Excess body weight adds load to already vulnerable hips, knees, and spine. Balanced calorie intake and regular gentle activity help limit pain and delay mobility limitations.
Risk prevention
Anauxetic dysplasia 2 is a rare genetic skeletal condition, so you can’t prevent the condition itself, but you can lower the chance of complications and protect day-to-day function. Prevention works best when combined with regular check-ups. Learning the early symptoms of Anauxetic dysplasia 2 can help families seek specialized care sooner and set up supports that make life easier.
Regular visits with a skeletal-dysplasia team can catch spine, hip, and leg alignment issues early. Monitoring can spot warning signs of spinal cord pressure or nerve problems before they cause lasting harm.
Low-impact activity like swimming or cycling helps joints stay mobile and muscles strong. A physical therapist can tailor exercises for Anauxetic dysplasia 2 and suggest ways to avoid neck and back strain.
Adequate calcium and vitamin D, plus balanced protein, support bone strength. Your care team may check vitamin D levels and guide supplements if needed.
Watch for loud snoring, pauses in breathing, or daytime sleepiness that could signal sleep-disordered breathing. A sleep study can guide treatment if symptoms are present.
Transmission
Anauxetic dysplasia 2 isn’t contagious; it can’t be caught or passed through everyday contact. Genetic transmission of Anauxetic dysplasia 2 follows an autosomal recessive pattern: a child must inherit two nonworking copies of the same gene, one from each parent, to have the condition. Parents are usually healthy carriers; when both are carriers, each pregnancy has a 25% (1 in 4) chance of an affected child, a 50% (1 in 2) chance the child will be a carrier, and a 25% chance of inheriting neither change. Families may have no prior history because carriers typically have no symptoms; the chance is higher when parents are closely related.
When to test your genes
Consider genetic testing if you or a close relative have extreme short stature from birth, spine or limb differences, or X‑rays showing markedly underdeveloped bones—especially if growth has stalled despite standard care. Testing can confirm Anauxetic dysplasia 2, guide surveillance for spine stability and airway risks, and inform family planning. If unsure, ask a genetics clinic for counseling and test options.
Diagnosis
Anauxetic dysplasia 2 is a rare, genetic skeletal condition, so clues often show up early as extreme short stature and distinctive bone changes. Day to day, families may notice growth that falls far below peers and delayed motor milestones. Getting a diagnosis is often a turning point toward answers and support. Doctors confirm the suspicion with imaging and genetic tests that look for the exact cause.
A specialist looks at growth, body proportions, joint movement, and any facial or limb differences. They also note features doctors commonly see in this condition to guide next steps.
Height, weight, and head size are charted over time to show the degree and pattern of growth restriction. Consistent, very low measurements compared with age norms can support suspicion of Anauxetic dysplasia 2.
A detailed family and health history can help identify inherited patterns or similar findings in relatives. This context helps decide which genetic tests are most useful.
Series of X-rays of the spine, chest, pelvis, arms, and legs look for a recognizable pattern of bone changes. Findings may include very small vertebral bodies and changes at the ends of long bones that fit this diagnosis.
Stages of Anauxetic dysplasia 2
Anauxetic dysplasia 2 does not have defined progression stages. It shows up early in life and tends to follow a steady course—very short stature and bone differences are present from the start, though spine curvature or joint issues may change over time. Different tests may be suggested to help confirm the diagnosis, including a physical exam, measurements, X-rays, and genetic testing. Doctors often monitor growth, spine alignment, and breathing over time; people or parents sometimes ask about early symptoms of Anauxetic dysplasia 2 because noticing changes can guide when to seek specialist care.
Outlook and prognosis
Looking ahead with Anauxetic dysplasia 2, day-to-day life often centers on managing very short stature, joint stiffness, and spine changes that can affect comfort and mobility. Many people ask, “What does this mean for my future?”, and the short answer is that most children grow into adulthood and can lead full lives with tailored orthopedic care, physical therapy, and regular monitoring for bone and airway issues. Early care can make a real difference, especially for spine alignment, hip stability, and breathing or sleep concerns that sometimes surface in childhood.
Prognosis refers to how a condition tends to change or stabilize over time. In Anauxetic dysplasia 2, growth remains significantly limited across the lifespan, but many other features can be supported so they don’t progress quickly or cause avoidable complications. Fractures are not typically a central feature, but joint contractures and back curvature may slowly increase and need periodic reassessment. Some early symptoms of Anauxetic dysplasia 2—like delayed motor milestones or frequent fatigue with activity—lead families to therapy sooner, which can improve function and confidence during school years.
The outlook is not the same for everyone, but most people with Anauxetic dysplasia 2 have a normal life expectancy when airway, spine, and heart health are monitored and treated promptly. Serious breathing problems are uncommon but can occur if spine curvature or chest shape limits lung space; sleep studies and pulmonary checks help catch issues early. With ongoing care, many people maintain independence in daily activities, pursue education and work, and adapt their homes or tools to match their height and mobility. Talk with your doctor about what your personal outlook might look like, including how often to screen for spine changes, sleep apnea, and any heart or airway concerns over time.
Long-term effects
Anauxetic dysplasia 2 is linked with lifelong skeletal changes that shape height, posture, and mobility. Over time, daily routines may revolve around adapting to short stature and spine or joint differences. Long-term effects vary widely, and many living with Anauxetic dysplasia 2 do well with regular monitoring. Some families recall what are often called early symptoms of Anauxetic dysplasia 2—like very slow length gain—being noticed in infancy, with the long-term picture becoming clearer as a child grows.
Height remains far below average into adulthood in Anauxetic dysplasia 2. Proportions can look different due to spine and limb bone changes. This short stature is a stable, lifelong feature.
Scoliosis or a forward curve of the back can increase over time. This may change posture and back comfort. In some, a pronounced curve can also reduce lung reserve.
Hip sockets can be shallow, leading to pain or a feeling of instability. This may limit range of motion and make longer walks tiring. Flare-ups often become more noticeable in adolescence and adulthood.
Loose joints can contribute to repeated sprains or early joint wear. For many with Anauxetic dysplasia 2, this shows up as pain or stiffness after activity. Over years, some joints can develop osteoarthritis.
How is it to live with Anauxetic dysplasia 2?
Living with anauxetic dysplasia 2 often means navigating very short stature from early childhood, frequent medical visits, and mobility adaptations like step stools, custom seating, or assistive devices for longer distances. Daily life can involve bone and joint monitoring, dental and ear care, and thoughtful planning for accessibility at school, work, and public spaces, while protecting independence and choice. Families, classmates, and coworkers may need guidance on respectful communication and practical support, and many find that linking with experienced clinicians and peer communities eases the learning curve. For many, a tailored care plan, environmental adjustments, and a supportive network make room for full participation in school, career, relationships, and hobbies.
Treatment and drugs
Treatment for Anauxetic dysplasia 2 focuses on easing symptoms, supporting growth and mobility, and monitoring for complications over time. Care is usually coordinated by a specialist team and can include physical therapy to protect joints and improve balance, orthotics or braces for limb alignment, and surgery in select cases for severe spine or limb deformities; doctors sometimes recommend a combination of lifestyle changes and drugs. Pain is managed with age‑appropriate medicines, while constipation, reflux, or sleep‑disordered breathing are treated as they arise. Because bone growth is limited by the underlying gene change, growth hormone has not been shown to help, and there’s currently no approved treatment that changes the course of Anauxetic dysplasia 2. Regular follow‑up for spine curvature, joint function, dental health, hearing, and nutrition is important, and supportive care can make a real difference in how you feel day to day.
Non-drug treatment
Day-to-day care for Anauxetic dysplasia 2 focuses on comfort, mobility, breathing, and safe growth, with supports that adapt as children become teens and adults. Non-drug treatments often lay the foundation for function, school participation, and family life. Plans are individualized and may change over time as joints, spine, and airway needs evolve. A coordinated team approach helps people stay active and reduce complications.
Gentle strengthening and stretching help joints move smoothly and support posture. Therapists tailor exercises to prevent stiffness and protect fragile areas.
Everyday skills like dressing, writing, or using utensils are broken into easier steps. Tools such as adapted grips or seating can boost independence at home and school.
Custom braces can steady ankles, knees, or wrists to improve balance and reduce fatigue. Spine bracing may help slow curve progression and ease pain during growth.
Regular checks and imaging track curves and neck stability over time. Early referral to an orthopedic spine team can prevent nerve pressure and protect mobility.
Your genes may have an impact on how drugs work for you
Even with a rare bone-growth condition like Anauxetic dysplasia 2, your genes can shape how your body absorbs, breaks down, and responds to certain medicines. Pharmacogenetics—matching drug choice and dose to genetic makeup—aims to boost benefit and reduce side effects.
Pharmacological treatments
There are no medicines that change bone growth in Anauxetic dysplasia 2, so drug therapy focuses on easing symptoms and treating complications. Medications for Anauxetic dysplasia 2 are tailored to the individual—based on pain levels, bone strength, breathing issues, and stomach or bowel symptoms. Not everyone responds to the same medication in the same way. Your care team will usually combine medicines with physical therapy, bracing, or procedures when needed.
Acetaminophen (paracetamol) or ibuprofen can help with day-to-day joint or back pain. Use weight-based dosing and avoid long-term NSAID use without medical advice. Tell your clinician if pain lasts or limits activity.
Vitamin D and calcium may be recommended after checking blood levels and diet. In select cases with low bone density or repeated fractures, specialists may use bisphosphonates such as pamidronate or zoledronic acid. These require monitoring for benefits and side effects.
Inhaled bronchodilators like albuterol (salbutamol) can ease wheeze or shortness of breath during flare-ups. Inhaled steroids such as budesonide or fluticasone may be added if symptoms are frequent. An action plan helps you know when to start or step up treatment.
Bacterial chest or ear infections are treated with antibiotics such as amoxicillin or amoxicillin–clavulanate, adjusted to local guidelines and allergies. Azithromycin may be used if penicillin isn’t an option. Seek care early if breathing worsens or fever persists.
Genetic influences
Anauxetic dysplasia 2 is caused by changes in a gene called POP1, which supports cell processes important for cartilage and bone growth. It follows a recessive (autosomal recessive) pattern, meaning a child develops the condition when they inherit two nonworking copies—one from each parent who typically has no symptoms. In this setting, each pregnancy has a 1 in 4 (25%) chance of a child being affected, a 1 in 2 (50%) chance the child will be a carrier, and a 1 in 4 (25%) chance of neither. A “carrier” means you hold the gene change but may not show symptoms. Genetic testing for Anauxetic dysplasia 2 can look for changes in POP1 and often confirms the diagnosis and carrier status within a family. Even within the same family, severity can differ, so while the inheritance pattern of Anauxetic dysplasia 2 explains risk, it does not predict the exact course for any one person.
Is Anauxetic dysplasia 2 genetic?
Genetics are central in Anauxetic dysplasia 2. It’s caused by inherited changes in a single gene, and most cases follow autosomal recessive patterns. Genetic testing confirms the diagnosis, guides family planning, and helps estimate recurrence risk for future pregnancies.
Pharmacogenetics—how genetics influence drug effects
Care for Anauxetic dysplasia 2 usually centers on orthopedic procedures, pain control, and managing airway or spine issues rather than a disease‑specific drug. The gene change that causes Anauxetic dysplasia 2 affects bone and cartilage development and isn’t known to directly change how the liver or kidneys handle medicines, but other common drug‑response genes can still matter during care. For example, genetic differences in the enzyme that activates codeine or tramadol can lead to poor pain relief in some people and stronger-than-expected effects in others, while well‑studied blood thinner genes can help fine‑tune warfarin dosing if it’s needed around surgery. Rare inherited traits can also influence anesthesia, such as slow breakdown of the muscle relaxant succinylcholine or a higher risk of malignant hyperthermia, so sharing any personal or family anesthesia reactions is important. Genetic testing can sometimes identify how your body processes certain pain medicines, which helps doctors choose safer options and doses. Even so, age, organ function, body size, and other medicines play a big role in what works and what’s safe for people living with Anauxetic dysplasia 2.
Interactions with other conditions
Colds, flu, or asthma can hit harder in people with Anauxetic dysplasia 2 because a smaller chest and possible airway narrowing may make breathing illness feel more taxing. Doctors call it a “comorbidity” when two conditions occur together, and in Anauxetic dysplasia 2, coexisting respiratory or heart problems can increase the risk around anesthesia and surgery, especially if there is sleep apnea or spine narrowing. Joint and spine changes may also magnify pain from arthritis or injuries, so a sprain or slipped disk can have a bigger day-to-day impact on walking and balance. Low bone density or vitamin D deficiency, when present, can raise fracture risk; treating these can lessen complications from otherwise minor falls. Some early symptoms of Anauxetic dysplasia 2, such as short stature and stiff joints, overlap with other skeletal conditions, which can make it easy to miss how another illness is adding to fatigue, pain, or breathing symptoms. Interactions can look very different from person to person, so coordinated care across orthopedics, pulmonology, cardiology, and anesthesia helps tailor plans when another condition is in the mix.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described children who stayed unusually short despite otherwise lively behavior and normal appetites. Families might recall a cousin who never outgrew toddler-size shoes or a grandparent remembered as “tiny but sturdy.” Before modern imaging, the pattern behind this type of very severe short stature was hard to see, and many living with it were grouped under broad labels like “dwarfism” without a precise name.
From early theories to modern research, the story of Anauxetic dysplasia 2 shows how careful observation led to clarity. Doctors first noticed a recognizable set of features: extreme short stature that begins before birth, bones that grow slowly, and a spine and chest that can look unusually shaped on X‑rays. Over time, descriptions became more detailed, separating Anauxetic dysplasia 2 from other skeletal conditions that can look similar in childhood. This helped families get more specific answers and set expectations for growth, mobility, and monitoring.
Advances in genetics then explained why the bones grow so slowly. Researchers linked Anauxetic dysplasia 2 to changes in a gene that helps cells manage their growth and structure. You can think of this gene as a kind of cellular “dimmer,” and in this condition the setting is turned down too low, so growth signals don’t translate into normal bone length. This genetic step forward confirmed that Anauxetic dysplasia 2 is distinct from related diagnoses and clarified inheritance, which supports accurate counseling for parents and future pregnancies.
In recent decades, awareness has grown as more centers share experience and images, and as genetic testing becomes more available. Earlier records often missed milder features or mixed different conditions together, which made it hard to compare outcomes. Despite evolving definitions, the core picture has held steady: very short stature from infancy, characteristic bone changes on imaging, and a growth pattern that is quite different from conditions that respond to hormone treatment.
Today, the history of Anauxetic dysplasia 2 guides care. Knowing the condition’s history helps clinicians order the right tests early, look for specific spine and chest findings, and connect families with specialists who understand the day‑to‑day needs that come with very small stature. It also reminds us why precise naming matters: when conditions are lumped together, families may receive advice that doesn’t fit; when they are carefully distinguished, care can be tailored and more supportive.